{"date":"2025-06-18","count":50,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1795-2025-06-18-2113-156xq8w","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-06-18","time":"21:13:00","subject":"本公司董事會通過子公司Lotus International Pte. Ltd.向DUY TAN PHARMACEUTICAL購買五個產品的越南藥證案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-06-18 21:13，「本公司董事會通過子公司Lotus International Pte. Ltd.向DUY TAN PHARMACEUTI」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-06-18-2110-1mpbjzz","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-06-18","time":"21:10:35","subject":"(補充114/5/9公告)變更本公司和LENZ Therapeutics, Inc. (以下簡稱”LENZ”) 簽署之獨家授權合作協議。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-06-18 21:10，「(補充114/5/9公告)變更本公司和LENZ Therapeutics, Inc. (以下簡稱”LENZ”) 簽署之獨」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-06-18-2017-rbboun","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"20:17:53","subject":"公告本公司審計委員會成員","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-06-18 20:17，「公告本公司審計委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-06-18-2017-ts4agr","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"20:17:31","subject":"公告本公司董事會決議薪資報酬委員會成員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-06-18 20:17，「公告本公司董事會決議薪資報酬委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-06-18-2017-18dku4c","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"20:17:08","subject":"公告本公司114年股東常會決議解除董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-06-18 20:17，「公告本公司114年股東常會決議解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-06-18-2016-1mn3azd","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"20:16:25","subject":"公告本公司114年股東常會增補選獨立董事當選名單暨董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-06-18 20:16，「公告本公司114年股東常會增補選獨立董事當選名單暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-06-18-2008-ds864w","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"20:08:23","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-06-18 20:08，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-06-18-1931-ds864w","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"19:31:55","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-06-18 19:31，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-06-18-1925-6kojnd","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"19:25:48","subject":"公告本公司法人董事代表人異動暨董事變動達三分之一","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-06-18 19:25，「公告本公司法人董事代表人異動暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-06-18-1839-1eymzho","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-06-18","time":"18:39:45","subject":"公告本公司自行撤回現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-06-18 18:39，「公告本公司自行撤回現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-06-18-1807-183qz27","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"18:07:32","subject":"本公司接獲進滿投資股份有限公司、進富投資股份有限公司、璽富投資股份有限公司、楊清宗及魏碧素等五人申報及公告之公開收購申報書、公開收購說明書及相關書件等有關收購通知之訊息說明","clause":"第38款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-06-18 18:07，「本公司接獲進滿投資股份有限公司、進富投資股份有限公司、璽富投資股份有限公司、楊清宗及魏碧素等五人申報及公告之公開收購申報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-06-18-1731-k2t7bu","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"17:31:51","subject":"代子公司共信寵物生醫股份有限公司向農業部動植物防疫檢疫署申請動物用藥品「安能康注射劑」專供輸出許可證登記事項案，已獲核准通知。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-06-18 17:31，「代子公司共信寵物生醫股份有限公司向農業部動植物防疫檢疫署申請動物用藥品「安能康注射劑」專供輸出許可證登記事項案，已獲核准」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-06-18-1718-1mfewjn","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"17:18:02","subject":"公告本公司調整配息率(更正現金股利總金額)","clause":"第14款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-06-18 17:18，「公告本公司調整配息率(更正現金股利總金額)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-06-18-1716-1m5w72h","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"17:16:03","subject":"公告本公司執行長任命案","clause":"第11款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-06-18 17:16，「公告本公司執行長任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-06-18-1705-3yz4l1","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"17:05:23","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)相關事宜(更正本公司原114年6月18日重大訊息)。","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-06-18 17:05，「公告本公司114年股東常會全面改選董事(含獨立董事)相關事宜(更正本公司原114年6月18日重大訊息)。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-06-18-1655-11r4gjr","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:55:16","subject":"公告本公司第二屆薪資報酬委員會委員任期屆滿","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-06-18 16:55，「公告本公司第二屆薪資報酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2025-06-18-1655-ds864w","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"16:55:07","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2025-06-18 16:55，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-06-18-1653-1r2d1uw","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:53:51","subject":"公告本公司第三屆審計委員會委員","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-06-18 16:53，「公告本公司第三屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-06-18-1652-1k32yj5","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-06-18","time":"16:52:45","subject":"代重要子公司正峰化學製藥(股)公司公告董事會通過董事長及總經理續任事宜","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-06-18 16:52，「代重要子公司正峰化學製藥(股)公司公告董事會通過董事長及總經理續任事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-06-18-1652-1pa5e7t","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"16:52:43","subject":"更正本公司114年股東常會議事手冊及各項議案參考資料(虧損金額及虧損撥補表金額誤植)","clause":"第44款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-06-18 16:52，「更正本公司114年股東常會議事手冊及各項議案參考資料(虧損金額及虧損撥補表金額誤植)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-06-18-1652-9769qc","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:52:24","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-06-18 16:52，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-06-18-1652-17x7flf","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-06-18","time":"16:52:24","subject":"代重要子公司正峰化學製藥(股)公司公告唯一法人股東重新指派董事及監察人","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-06-18 16:52，「代重要子公司正峰化學製藥(股)公司公告唯一法人股東重新指派董事及監察人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-06-18-1651-1e7iplt","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-06-18","time":"16:51:56","subject":"公告本公司董事會通過委任第六屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-06-18 16:51，「公告本公司董事會通過委任第六屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-06-18-1651-1lpjnok","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-06-18","time":"16:51:31","subject":"公告本公司董事會通過總經理續任事宜","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-06-18 16:51，「公告本公司董事會通過總經理續任事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-06-18-1650-1au9z19","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:50:55","subject":"公告本公司114年股東常會解除董事競業禁止限制","clause":"第22款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-06-18 16:50，「公告本公司114年股東常會解除董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-06-18-1648-wo1ldg","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:48:48","subject":"公告本公司114年股東常會董事全面改選當選名單","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-06-18 16:48，「公告本公司114年股東常會董事全面改選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-06-18-1645-hiebb2","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:45:29","subject":"公告本公司114年股東會重要決議事項","clause":"第15款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-06-18 16:45，「公告本公司114年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-06-18-1644-o3x3vh","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:44:11","subject":"公告本公司經主管機關核准調整現金增資發行股數及繳款期限","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-06-18 16:44，「公告本公司經主管機關核准調整現金增資發行股數及繳款期限」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-06-18-1638-1dfivnh","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:38:35","subject":"公告本公司第三屆薪酬委員會委員。","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-06-18 16:38，「公告本公司第三屆薪酬委員會委員。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-06-18-1638-larrie","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:38:11","subject":"公告本公司第三屆審計委員會名單。","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-06-18 16:38，「公告本公司第三屆審計委員會名單。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-06-18-1637-m1o27r","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:37:56","subject":"公告本公司董事會決議通過委任第六屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-06-18 16:37，「公告本公司董事會決議通過委任第六屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-06-18-1637-w3vpr7","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:37:40","subject":"公告本公司董事會推選董事長及副董事長。","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-06-18 16:37，「公告本公司董事會推選董事長及副董事長。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-06-18-1637-1owpdgj","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:37:09","subject":"公告本公司114年股東常會解除新任董事競業禁止之限制案。","clause":"第22款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-06-18 16:37，「公告本公司114年股東常會解除新任董事競業禁止之限制案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-06-18-1636-s0kpz3","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:36:56","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-06-18 16:36，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-06-18-1636-mn1j21","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:36:33","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)相關事宜。","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-06-18 16:36，「公告本公司114年股東常會全面改選董事(含獨立董事)相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-06-18-1635-jnf97a","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:35:54","subject":"公告本公司114年股東常會重要決議事項。","clause":"第15款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-06-18 16:35，「公告本公司114年股東常會重要決議事項。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-06-18-1635-1629w2u","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:35:25","subject":"公告本公司114年股東常會決議解除新任董事及其代表人競業禁止之限制","clause":"第22款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-06-18 16:35，「公告本公司114年股東常會決議解除新任董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-06-18-1634-1r2d1uw","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:34:28","subject":"公告本公司第三屆審計委員會委員","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-06-18 16:34，「公告本公司第三屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-06-18-1632-1p4s8c3","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:32:49","subject":"公告本公司114年股東會董事(含獨立董事)全面改選當選名單","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-06-18 16:32，「公告本公司114年股東會董事(含獨立董事)全面改選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-06-18-1630-ds864w","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:30:50","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-06-18 16:30，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-06-18-1619-2ngh41","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"16:19:04","subject":"公告本公司董事會決議委任第四屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-06-18 16:19，「公告本公司董事會決議委任第四屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-06-18-1430-ijxeb8","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"14:30:16","subject":"代重要子公司潤雅生技股份有限公司公告114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-06-18 14:30，「代重要子公司潤雅生技股份有限公司公告114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2025-06-18-1415-1r2d1uw","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"14:15:23","subject":"公告本公司第三屆審計委員會委員","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2025-06-18 14:15，「公告本公司第三屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2025-06-18-1415-sa28ar","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"14:15:04","subject":"公告本公司董事會決議聘任第六屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2025-06-18 14:15，「公告本公司董事會決議聘任第六屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2025-06-18-1414-1gm77fo","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"14:14:44","subject":"公告本公司董事會選任董事長案","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2025-06-18 14:14，「公告本公司董事會選任董事長案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2025-06-18-1414-1n0t8dn","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"14:14:29","subject":"本公司114年股東常會改選董事（含獨立董事)當選名單","clause":"第6款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2025-06-18 14:14，「本公司114年股東常會改選董事（含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2025-06-18-1414-ds864w","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"14:14:08","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2025-06-18 14:14，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2025-06-18-1411-hsfx1y","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"14:11:10","subject":"公告本公司114年股東常會決議通過解除董事及其代表人競業禁止限制案","clause":"第22款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2025-06-18 14:11，「公告本公司114年股東常會決議通過解除董事及其代表人競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2025-06-18-1358-d9bwy4","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2025-06-18","time":"13:58:29","subject":"公告本公司114年度股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2025-06-18 13:58，「公告本公司114年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-06-18-1333-1cza5x2","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-06-18","time":"13:33:30","subject":"本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-06-18 13:33，「本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}